I found this... Looks like they are just position
Post# of 154307
(Total Views: 332)
Posted On: 04/02/2019 8:45:46 AM
I found this... Looks like they are just positioning themselves inline with current cancer care pricing.. From 1995 to 2014, in fact, there was a sharp increase in the launch price of new cancer drugs—that is, the cost of a new drug being introduced to the market for the first time. Most cancer drugs launched between 2009 and 2014 were priced at more than $100,000 per patient for one year of treatment. More recently, we’ve seen launch prices of more than $400,000 for a year of treatment.
Found this somewhere else.
What makes cancer such a financial killer? Average costs for treatment run in the $150,000 range. The reasons aren’t mysterious. Cancers occur at the cellular level, with abnormal cells dividing and spreading. Containing the cancer and killing those abnormal cells without damaging nearby healthy cells often requires a range of treatments over an extended period of time — lengthy radiation, complicated surgeries, costly chemotherapy, plus other strong medications to supercharge your immunity.
Cancer drug costs fluctuate all the time, increasing and decreasing whenever the manufacturer sees fit to change the price. Take Novartis' leukemia drug Gleevec, which cost $24,000 in 2001 when it was approved as a breakthrough drug; now it costs $90,000, according to Forbes. Unfortunately for patients, the cost has little to do with efficacy of the drug or its safety.
So it seems to vary quite a bit. 120 does seem a little high, but maybe because it works so well, they may think that they will be able to use less and charge a little more. IMHO.. It will probably change a few times before a real price is set in stone.
Found this somewhere else.
What makes cancer such a financial killer? Average costs for treatment run in the $150,000 range. The reasons aren’t mysterious. Cancers occur at the cellular level, with abnormal cells dividing and spreading. Containing the cancer and killing those abnormal cells without damaging nearby healthy cells often requires a range of treatments over an extended period of time — lengthy radiation, complicated surgeries, costly chemotherapy, plus other strong medications to supercharge your immunity.
Cancer drug costs fluctuate all the time, increasing and decreasing whenever the manufacturer sees fit to change the price. Take Novartis' leukemia drug Gleevec, which cost $24,000 in 2001 when it was approved as a breakthrough drug; now it costs $90,000, according to Forbes. Unfortunately for patients, the cost has little to do with efficacy of the drug or its safety.
So it seems to vary quite a bit. 120 does seem a little high, but maybe because it works so well, they may think that they will be able to use less and charge a little more. IMHO.. It will probably change a few times before a real price is set in stone.
(2)
(0)